|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/215 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 2898885 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14198125.8 |
| Date of filing the European patent application | 2011-10-14 | |
| (97) | Date of publication of the European application | 2015-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation | 2018-02-26 |
| (30) | Number | Date | Country code |
| 393522 P | 2010-10-15 | US | |
| 201161492054 P | 2011-06-01 | US |
| (72) |
Bantia, Shanta, US
Kotian, Pravin L, US
Babu, Yarlagadda S, US
|
| (73) |
Biocryst Pharmaceuticals, Inc.,
4505 Emperor Blvd., Durham, North Carolina 27703,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pirolopirimidino dariniai, skirti naudoti virusinių infekcijų gydymui |
| Pyrrolopyrimidine derivatives for use in the treatment of viral infections |
| Payment date | Validity (years) | Amount | |
| 2025-09-17 | 15 | 289.00 EUR |
| 2026-10-14 |